Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer (FLT3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02839265
Recruitment Status : Active, not recruiting
First Posted : July 20, 2016
Last Update Posted : September 2, 2021
Sponsor:
Collaborator:
Celldex Therapeutics
Information provided by (Responsible Party):
Nitin Ohri, Albert Einstein College of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 8, 2021
Estimated Study Completion Date : September 8, 2021